Related references
Note: Only part of the references are listed.Early-stage Parkinson's patients show selective impairment in reactive but not proactive inhibition
Veronica Di Caprio et al.
MOVEMENT DISORDERS (2020)
Validation of Revised Chinese Version of PD-CRS in Parkinson's Disease Patients
Yuyan Tan et al.
PARKINSONS DISEASE (2020)
Montreal Cognitive Assessment for evaluating the cognitive impairment in patients with schizophrenia: A systematic review
Elena Cecilia Rosca et al.
GENERAL HOSPITAL PSYCHIATRY (2020)
Montreal Cognitive Assessment (MoCA) for HIV-Associated Neurocognitive Disorders
Elena Cecilia Rosca et al.
NEUROPSYCHOLOGY REVIEW (2019)
Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review
Klaus Seppi et al.
MOVEMENT DISORDERS (2019)
A re-examination of Montreal Cognitive Assessment (MoCA) cutoff scores
Nicole Carson et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2018)
Global Scales for Cognitive Screening in Parkinson's Disease: Critique and Recommendations
Matej Skorvanek et al.
MOVEMENT DISORDERS (2018)
Effects of Antiparkinson Medication on Cognition in Parkinson's Disease: A Systematic Review
Marc-Andre Roy et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2018)
Mild Cognitive Impairment in Parkinson's Disease-What Is It?
Rimona S. Weil et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2018)
Validation of the MDS clinical diagnostic criteria for Parkinson's disease
Ronald B. Postuma et al.
MOVEMENT DISORDERS (2018)
Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
E. Ray Dorsey et al.
LANCET NEUROLOGY (2018)
Accuracy of Two Cognitive Screening Tools to Detect Mild Cognitive Impairment in Parkinson's Disease
Emmie W. Koevoets et al.
MOVEMENT DISORDERS CLINICAL PRACTICE (2018)
Cognition and the Course of Prodromal Parkinson's Disease
Daniel Weintraub et al.
MOVEMENT DISORDERS (2017)
Cognitive Changes in Prodromal Parkinson's Disease: A Review
Sophie Fengler et al.
MOVEMENT DISORDERS (2017)
Mild Cognitive Impairment as a Risk Factor for Parkinson's Disease Dementia
Jeroen Hoogland et al.
MOVEMENT DISORDERS (2017)
The Parkinson's Disease-Cognitive Rating Scale (PD-CRS): normative values from 268 healthy Italian individuals
Gabriella Santangelo et al.
NEUROLOGICAL SCIENCES (2017)
Natural course of mild cognitive impairment in Parkinson disease A 5-year population-based study
Kenn Freddy Pedersen et al.
NEUROLOGY (2017)
Inhibitory control is not lateralized in Parkinson's patients
G. Mirabella et al.
NEUROPSYCHOLOGIA (2017)
Development and validation of an alternative version of the Parkinson's Disease-Cognitive Rating Scale (PD-CRS)
Ramon Fernandez-Bobadilla et al.
PARKINSONISM & RELATED DISORDERS (2017)
Association Between Poor Cognitive Functioning and Risk of Incident Parkinsonism The Rotterdam Study
Sirwan K. L. Darweesh et al.
JAMA NEUROLOGY (2017)
Apolipoprotein Eε4: A Biomarker for Executive Dysfunction among Parkinson's Disease Patients with Mild Cognitive Impairment
Nor A. Samat et al.
FRONTIERS IN NEUROSCIENCE (2017)
Mild cognitive impairment in Parkinson's disease: a distinct clinical entity?
Ming-Ching Wen et al.
TRANSLATIONAL NEURODEGENERATION (2017)
Validation of the Parkinson's Disease-Cognitive Rating Scale Applying the Movement Disorder Society Task Force Criteria for Dementia Associated with Parkinson's Disease
Marcos Serrano-Duenas et al.
MOVEMENT DISORDERS CLINICAL PRACTICE (2017)
Cognitive function in the early phase of Parkinson's disease, a five-year follow-up
M. E. Domellof et al.
ACTA NEUROLOGICA SCANDINAVICA (2015)
Does Response Inhibition Have Pre- and Postdiagnostic Utility in Parkinson's Disease?
Hayley J. MacDonald et al.
JOURNAL OF MOTOR BEHAVIOR (2015)
Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis
Hui-Fu Wang et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Parkinson's Disease, the Subthalamic Nucleus, Inhibition, and Impulsivity
Marjan Jahanshahi et al.
MOVEMENT DISORDERS (2015)
Complementary Therapies for Parkinson's Disease: What's Promoted, Rationale, Potential Risks and Benefits
Marcie L. Rabin et al.
MOVEMENT DISORDERS CLINICAL PRACTICE (2015)
Montreal Cognitive Assessment for the diagnosis of Alzheimer's disease and other dementias
Daniel H. J. Davis et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2015)
Validation of the Italian version of Parkinson's Disease-Cognitive Rating Scale (PD-CRS)
Gabriella Santangelo et al.
NEUROLOGICAL SCIENCES (2014)
Characterizing mild cognitive impairment in incident Parkinson disease The ICICLE-PD Study
Alison J. Yarnall et al.
NEUROLOGY (2014)
Test Accuracy of Cognitive Screening Tests for Diagnosis of Dementia and Multidomain Cognitive Impairment in Stroke
Rosalind Lees et al.
STROKE (2014)
Mild cognitive impairment in Parkinson's disease
Alison Jane Yarnall et al.
AGE AND AGEING (2013)
Practitioner Review: Do performance-based measures and ratings of executive function assess the same construct?
Maggie E. Toplak et al.
JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY (2013)
Parkinson's Disease-Cognitive Rating Scale: Psychometrics for Mild Cognitive Impairment
Ramon Fernandez de Bobadilla et al.
MOVEMENT DISORDERS (2013)
Is It Time to Rethink How Neuropsychological Tests Are Used to Diagnose Mild Forms of HIV-Associated Neurocognitive Disorders? Impact of False-Positive Rates on Prevalence and Power
Ana-Claire L. Meyer et al.
NEUROEPIDEMIOLOGY (2013)
Acute and chronic cognitive effects of levodopa and dopamine agonists on patients with Parkinson's disease: a review
Michele Poletti et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2013)
Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease
Daniel Weintraub et al.
BRAIN (2012)
Clinical Validity of the Mattis Dementia Rating Scale-2 in Parkinson Disease With MCI and Dementia
Evelyne Matteau et al.
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2012)
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines
Irene Litvan et al.
MOVEMENT DISORDERS (2012)
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Marilyn S. Albert et al.
ALZHEIMERS & DEMENTIA (2011)
QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies
Penny F. Whiting et al.
ANNALS OF INTERNAL MEDICINE (2011)
Neurodegeneration Across Stages of Cognitive Decline in Parkinson Disease
Daniel Weintraub et al.
ARCHIVES OF NEUROLOGY (2011)
The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence?
Magnus Gisslen et al.
BMC INFECTIOUS DISEASES (2011)
Mortality from Parkinson's disease: A population-based prospective study (NEDICES)
Ignacio J. Posada et al.
MOVEMENT DISORDERS (2011)
Characterizing Mild Cognitive Impairment in Parkinson's Disease
John C. Dalrymple-Alford et al.
MOVEMENT DISORDERS (2011)
MDS Task Force on Mild Cognitive Impairment in Parkinson's Disease: Critical Review of PD-MCI
Irene Litvan et al.
MOVEMENT DISORDERS (2011)
Performance of Greek Demented and Nondemented Subjects on the Greek Version of the Mattis Dementia Rating Scale. A Validation Study
Zoe Katsarou et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2010)
Mild cognitive impairment in Parkinson disease A multicenter pooled analysis
D. Aarsland et al.
NEUROLOGY (2010)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Executive and motivational inhibition: Associations with self-report measures related to inhibition
Jill Shuster et al.
CONSCIOUSNESS AND COGNITION (2009)
Parkinson's Disease Dementia: Definitions, Guidelines, and Research Perspectives in Diagnosis
Christopher G. Goetz et al.
ANNALS OF NEUROLOGY (2008)
The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
Mariese A. Hely et al.
MOVEMENT DISORDERS (2008)
Parkinson's disease-cognitive cognitive scale specific for rating scale: A new Parkinson's disease
Javier Pagonabarraga et al.
MOVEMENT DISORDERS (2008)
Clinical diagnostic criteria for dementia associated with Parkinson's disease
Murat Emre et al.
MOVEMENT DISORDERS (2007)
Assessing cognitive change in Parkinson's disease:: Development of practice effect-corrected reliable change indices
Alexander I. Troester et al.
ARCHIVES OF CLINICAL NEUROPSYCHOLOGY (2007)
Risk factors for incident dementia in England and Wales: The medical research council cognitive function and ageing study. A population-based nested case-control study
AG Yip et al.
AGE AND AGEING (2006)
Prognosis of Parkinson disease - Risk of dementia and mortality: The Rotterdam Study
LML de Lau et al.
ARCHIVES OF NEUROLOGY (2005)
The montreal cognitive assessment, MoCA:: A brief screening tool for mild cognitive impairment
ZS Nasreddine et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2005)
Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom
P Hobson et al.
MOVEMENT DISORDERS (2004)
Assessment of cognition in Parkinson's disease
J Marinus et al.
NEUROLOGY (2003)
Risk of dementia in Parkinson's disease - A community-based, prospective study
D Aarsland et al.
NEUROLOGY (2001)
Share Paper
